北京康辰药业股份有限公司关于股份回购进展公告

Group 1 - The company has approved a share repurchase plan using its own or raised funds, with a total repurchase amount between RMB 50 million and RMB 100 million, and a maximum repurchase price of RMB 82 per share, within a 12-month period [1] Group 2 - As of October 31, 2025, the company has repurchased a total of 397,400 shares, representing 0.25% of the total share capital, with a total expenditure of RMB 20,161,793, at a maximum price of RMB 51.40 per share and a minimum price of RMB 49.69 per share [2] Group 3 - The company will adhere to relevant regulations and make repurchase decisions based on market conditions, ensuring timely information disclosure regarding the progress of the share repurchase [3]